-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2019: 6:00 PM-8:00 PM
Hall B, Level 2 (Orange County Convention Center)

Michael D. Jain, MD, PhD1, Rawan Faramand, MD2, Verena Staedtke, MD PhD3*, Renyuan Bai, MBBS3*, Sae Bom Lee4*, Hiroshi Kotani, MD, PhD4*, Kayla Reid5*, Kristen Spitler4*, Julio Chavez6*, Bijal Shah, MD7, Christina A Bachmeier, PharmD1*, Marian Dam, ARNP8*, Brigett Brandjes, PA2*, Ricardo J Gonzalez, MD9*, John E Mullinax, MD PhD9*, Xuefeng Wang, PhD8*, Mohammad Hussaini, MD10*, Frederick L. Locke, MD2 and Marco L. Davila, MD, PhD2

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
2Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
3Depts. of Neurology and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD
4Clinical Science Division, Moffitt Cancer Center, Tampa, FL
5Division of Clinical Science, Moffitt Cancer Center, Tampa, FL
6Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
7Division of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Moffitt Cancer Center, Tampa, FL
9Sarcoma Department, Moffitt Cancer Center, Tampa, FL
10Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Mattia Novo1,2*, M Hasib Sidiqi, MBBS2,3, Jonas Paludo, MD2, Sangeetha Gandhi, MBBS2*, Jilan Kubusek, PharmD2*, Tuan Truong2*, Justin Hayne2*, Stephen M. Ansell, MD, PhD2, N. Nora Bennani, MD2, Jose C Villasboas2*, Adrienne Nedved, Pharm.D., R, Ph2*, Gina Lange2*, Eva Brandes2*, Hassan B. Alkhateeb, MD2*, David Dingli, MD, PhD2, Suzanne R. Hayman, MD2, Prashant Kapoor, MD2, Saad S. Kenderian, MD2, Taxiarchis Kourelis, MD2, Shaji K. Kumar, MD2, Mithun Vinod Shah, MD, PhD2, Mustaqeem Siddiqui, MD2*, Rahma M Warsame, MD2, Patrick Johnston, MD, PhD2 and Yi Lin, MD, PhD2

1Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, TORINO, Italy
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology, Fiona Stanley Hospital, Perth, Australia

Caron A. Jacobson, MD1, Alex F. Herrera, MD2, Lihua E Budde, MD, PhD3, Daniel J. DeAngelo, MD4, Christopher Heery, MD5*, Anthony Stein, MD6, Michael D. Jain, MD, PhD7 and Bijal Shah, MD8

1Department of Medical Oncology, Dana Faber Cancer Institute, Boston, MA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
3T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
4Department of Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
5Precision BioSciences, Durham, NC
6City of Hope National Medical Center, Duarte, CA
7Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
8Division of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Sunita Dwivedy Nasta, MD1, Mitchell E. Hughes, PharmD1*, Esin C. Namoglu, B.S.1*, Daniel J. Landsburg, MD1, Elise A. Chong, MD1, Stefan K. Barta, MD, MRCP, MS1, Noelle V. Frey, MD2, James N. Gerson, MD1, Amit Maity, MD, PhD3*, John Plastaras, MD3*, David L. Porter, MD2, Marco Ruella, MD4, Jakub Svoboda, MD1, Hatcher J. Ballard, BS1* and Stephen J. Schuster, MD1

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
3Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
4Center for Cellular Immunotherapies and Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA

Daria Gaut, MD1, Kevin Tang, BS, BA2*, Myung Sim, PhD3*, Tuyen Duong3*, Joshua Sasine, MD, PhD4 and Patricia A. Young, MD4

1Department of Medicine, University of California Los Angeles, Los Angeles, CA
2University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA
3Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, CA
4Division of Hematology and Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA

Alfredo Rivas-Delgado1,2,3, Ferran Nadeu2,3,4*, Anna Enjuanes4,5*, Sebastián Casanueva6*, Laura Magnano2,7*, Natalia Castrejón de Anta8*, Jordina Rovira1*, Ivan Dlouhy9*, Pablo Mozas1*, Silvia Martín2,4*, Miguel Osuna8*, Tycho Baumann1,2,4*, Julio Delgado1,2,3,4*, Balagué Olga2,4,8*, Sílvia Beà2,3,4*, Neus Villamor2,4,7*, Xavier Setoain2,6*, Elías Campo2,3,4,8*, Eva Gine, MD1,2,4 and Armando Lopez-Guillermo1,2,3,4

1Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
2Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
3Universitat de Barcelona, Barcelona, Spain
4Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
5Unitat de Genòmica, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
6Nuclear Medicine Department, Hospital Clínic de Barcelona, Barcelona, Spain
7Hematology Service, Hospital Clinic, Barcelona, Spain
8Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain
9Hematology, Instituto Português de Oncologia, Lisbon, Portugal

Karin Ekstrom Ekstroem Smedby1,2,3*, Sara Ekberg3*, Sandra Eloranta4*, Gunilla Enblad5*, Mats Jerkeman, MD, Professor6, Per-Ola Andersson, MD, PhD7* and Sara Harrysson, MD3,8*

1Karolinska University Hospital, Stockholm, Sweden
2Karolinska University Hospital, Stockholm, Stockholm, Sweden
3Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
4Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
6Dept of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Lund, Sweden
7Dept of Hematology, South Älvsborg Hospital, Borås, Sweden
8Dept of Hematology, Karolinska University Hospital, Solna, Sweden

Charline Moulin1*, Romain Morizot1*, Thomas Remen2*, Hélène Augé1*, Florian Bouclet3*, Marion Divoux4*, Sandra Lomazzi5*, Caroline Dartigeas, MD6*, Anne Quinquenel, MD7*, Hélène Busby, MD8*, Cecile Tomowiak9*, Veronique Leblond, MD, PhD10, Catherine Thieblemont, MD PhD11, Florence Cymbalista, MD, PhD12*, Marie C Bene, PharmD, DPhil13*, Romain Guièze, MD PhD14*, Julien Broseus, MD, PhD15* and Pierre Feugier, MD, PhD1*

1Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
2Unit of Methodology and Statistics, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
3CHU Estaing, Unit of adult cell therapy and clinical hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, Auvergne, France
4Hematology Department, Nancy University Hospital, Vandoeuvre, France
5Biocollection repository, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
6Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Bretonneau, Tours, France
7Hematology Department, Robert Debré University Hospital, Reims, France
8Pathology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
9Department of Oncology-Haematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
10Service d'hématologie, Hopital Pitie-Salpetriere, Sorbonne Université, Paris, FRA
11Hematology Department, Hospital Saint-Louis, Paris, France
12Laboratoire d'Hématologie, APHP Hôpital Avicenne, Bobigny, France
13Hematology Biology, Nantes University Hospital, Nantes, France
14CHU Estaing, Unit of adult cell therapy and clinical hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, MA, France
15Laboratory Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France

Fredrik Ellin, MD, MSc1*, Knut B. Smeland2*, Tove Wästerlid, MD, PhD3*, Jacob H. Christensen, MD4*, Judit Jørgensen, MD, PhD5*, Pär L. Josefsson6, Harald Holte, MD, PhD2, Yngvild Nuvin Blaker, MD, PhD7*, Jacob H. Grauslund8*, Jon Bjoern9*, Daniel Molin10*, Ingemar Lagerlöf, MD11*, Karin Ekstrom Ekstroem Smedby12*, Katherine Colvin13*, Gita Thanarajasingam, MD14, Matthew J Maurer, MS15*, Thomas M. Habermann, MD14, Kevin Song, MD16, Katie Yuan Zhu, BSc17*, Alina S Gerrie, MD, MPH18, Chan Y. Cheah19, Tarec Christoffer C. El-Galaly, MD20 and Lasse H. Jakobsen, PhD21*

1Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden
2Department of Oncology, Oslo University Hospital, Oslo, Norway
3Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
4Department of Hematology, Odense University Hospital, Odense, Denmark
5Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
6Department of Hematology, Herlev University Hospital, Herlev, Denmark
7KG. Jebsen Centre for B cell malignancies, University of Oslo, Oslo, Norway
8Department of Hematology, Roskilde Sygehus, Roskilde, Denmark
9Department of Hematology, Rigshospitalet, Copenhagen, Denmark
10Academic Hospital–Uppsala University Hospital, Uppsala, Sweden
11University Hospital Linköping, Linköping, Sweden
12Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
13Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
14Division of Hematology, Mayo Clinic, Rochester, MN
15Mayo Clinic, Rochester
16University of British Columbia, Division of Hematology and Leukemia/BMT Program of BC, Vancouver, BC, Canada
17University of British Columbia, Vancouver, BC, CAN
18Leukemia/BMT Program of BC and Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada
19NW Cancer Centre, Perth, WEA, Australia
20Aalborg University Hospital, Aalborg, Denmark
21Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Andres JM Ferreri, MD1, Teresa Calimeri, MD PhD2, Paolo Lopedote, MD3*, Ilaria Francaviglia4*, Rita Daverio, MD5*, Chiara Iacona4*, Cristina Belloni, BD5*, Sara Steffanoni, MD6*, Elena Anghileri, MD7*, Angelo Diffidenti6*, Annamaria Finardi, BD8*, Filipppo Gagliardi, MD9*, Nicoletta Anzalone, MD10*, Alessandro Nonis11*, Roberto Furlan, MD8*, Piera Angelillo, MD12*, Marianna Sassone, MD13*, Daniela De Lorenzo, BD14*, Maria Rosa Terreni, MD4*, Marco Foppoli15*, Elena Guggiari, MD16*, Vittoria Tarantino, MD6*, Marika Eoli, MD7*, Fabio Ciceri, MD17*, Claudio Doglioni18*, Massimo Locatelli, MD5*, Maurilio Ponzoni, MD19 and Maria Giulia Cangi18*

1Lymphoma Unit, Dept. of Onco-Hematology, IRCCS Istituto Scientifico San Raffaele, Milan, Italy
2Lymphoma Unit, Dept of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
3Lymphoma Unit, Dept. of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
4Pathology Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
5Division of Lab Medicine, IRCCS San Raffaele Scientific Institute, Milano, Italy
6Lymphoma Unit, Dept. of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
7Molecular Neuro-Oncology Unit, IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
8Clinical Neuroimmunology Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
9Neurosurgery unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
10Neuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
11Università Vita-Salute San Raffaele, Milano, ITA
12Lymphoma Unit, Dept of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
13Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
14Lymphoma Unit, Dept. of Onco-Hematology, IRCCS San Raffaele Scientific institute, Milano, Italy
15Lymphoma Unit, Dept. of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, ITA
16Haematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milan, Italy
17Ospedale San Raffaele, Milano, Italy
18Pathology Unit, IRCCS San Raffaele Scientific Institute, Milano, ITA
19Pathology Unit, San Raffaele Scientific Institute, Milano, Italy

Clarisse Cazelles1*, Karim Belhadj2*, Helene Vellemans3*, Vincent Camus4*, Christiane Copie, MD PhD5*, Liana Veresezan, MD6*, Emmanuel Itti, MD, PhD7*, Stephanie Becker, MD8*, Muriel verlinde Carvalho9*, Jehan Dupuis, MD10*, Fabien Le Bras11*, Francois Lemonnier, MD, PhD12*, Louise Roulin, MD13*, Taoufik El Gnaoui14*, Fabrice Jardin15*, Nicolas Mounier, MD16*, Herve Tilly, MD, PhD17 and Corinne Haioun, MD, PhD18*

1Necker Hospital, Paris, France
2lymphoid malignancies, Centre Hospitalier Universitaire Henri Mondor, Créteil, France
3Hospital, Yvoir, BEL
4Centre Henri Becquerel, Rouen, FRA
5Pathology, Henri Mondor Hospital, Creteil, France
6Department of Pathology, Centre Henri Becquerel, Rouen, France
7Service de médecine nucléaire, CHU Henri Mondor, Creteil, FRA
8Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France
9Henri Mondor Hospital, Cretil, France
10Henri Mondor Hospital, CRETEIL, France
11Unité hémopathies Lymphoïdes, Hopital Henri Mondor, Creteil Cedex, France
12Unité Hémopathie Lymphoïde, Hôpital Henri Mondor & Université Paris Est Créteil, Créteil, France
13Lymphoid Malignancies, Henri Mondor Hospital, Créteil, France
14Henri Mondor Hospital, CRETEIL, PA, France
15Department of Hematology, Centre Henri Becquerel, Rouen, France
16CHU de Nice, Nice, FRA
17Department of Hematology, Centre de Lutte Contre le Cancer Henri Becquerel, Rouen, France
18Lymphoid Malignancies Unit, Henri Mondor University Hospital, APHP, Créteil, France

Anna Dodero, MD1*, Anna Guidetti, MD1, Fabrizio Marino, MD2*, Cristiana Carniti, PhD1*, Stefania Banfi1*, Alessandra Tucci, MD3*, Monica Balzarotti2*, Antonello Domenico Cabras, MD4*, Valentina Monti, PhD4*, Liliana Franca Devizzi, MD1*, Lucia Farina, MD1*, Maria Chiara Di Chio, MD1*, Giuseppe Rossi5, Carmelo Carlo-Stella, MD6 and Paolo Corradini, MD7

1Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Department of Hematology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy
3Department of Hematology, ASST Spedali Civili, Brescia, Italy
4Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
5Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
6Department of Hematology, Humanitas Cancer Center, Rozzano, Milano, Italy
7Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy

Peiqi Zhao1*, Huilai Zhang2*, Kai Fu, MD, PhD1,3, Xianhuo Wang, MD1*, Lanfang Li1*, Zhengzi Qian1*, Lihua Qiu1* and Shiyong Zhou1*

1Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
2Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia Research, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
3Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Haruya Okamoto, MD1*, Akihiro Miyashita, MD1*, Hiroaki Nagata, MD1*, Yasuhiko Tsutsumi, MD, PhD1*, Yuri Kamitsuji, MD, PhD1*, Yutaka Kobayashi, MD, PhD1* and Nobuhiko Uoshima, MD, PhD2*

1Hematology, Japanese Red Cross Society Kyoto Daini Hospital, kyoto, Japan
2Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan

Shinji Ogura, MD1*, Masahiro Akimoto1*, Aki Sakurai, MD1*, Chisako Ito1*, Yuriko Fujita1*, Yoshinobu Aisa1* and Tomonori Nakazato, MD, PhD2

1Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan
2Department of Hematology, Yokohama Municipal Citizen's Hospital, Tokyo, Japan

Jacob Orme, MD, PhD1, Jose Villasboas, M.D.2 and Haidong Dong, MD PhD1*

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN

Denisse A. Castro, MD1,2, Brady E. Beltrán, MD1,2*, Luis Villela M3,4*, Marialejandra Torres Viera, MD5,6*, Victoria Otero, MD7*, Lorena Fiad, MD8*, Camila Peña, MD9, Henry Idrobo, MD10,11,12*, Christine Rojas, MD13,14*, Ivan Perdomo, MD15*, Pilar León, MD16*, Karen Lalupu, MD1*, Sally Rose Paredes, MD1*, Fernando Pérez-Jacobo, MD17, Ana Ramirez-Ibarguen, MD18*, David Gomez-Almaguer, MD19,20, Jose A Hernández-Hernández, PhD21*, Myrna Candelaria, MD, PharmD22, Guillermo J. Ruiz-Arguelles, FRCP, MACP23, Andrés Gómez-De León, MD20, Efreen Montaño Figueroa, PhD24*, Melani Otañez, MD25*, Carlos Best, MD26*, Luis E Malpica Castillo, MD27, Eduardo Sotomayor, MD28 and Jorge J. Castillo, MD29,30

1Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
2Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
3Campus Hermosillo, Universidad del Valle de Mexico, Monterrey, Nuevo Leon, Mexico
41) Hospital Dr. Ignacio Chavez, ISSSTESON,Hermosillo,Son,Mex, Hermosillo, SO, Mexico
5Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of)
6Clinica Santa Sofia, Caracas, VEN
7Sección Hematología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
8Hematología, Hospital Italiano de La Plata, La Plata, Argentina
9Hematology department, Hospital Del Salvador, Santiago, Chile
10Facultad de Medicina., Profesor Universidad Del Valle, Cali, Colombia
11Facultad de Medicina., Universidad Libre, Cali, Colombia
12Hospital Universitario del Valle, Cali, Colombia
13Sociedad Chilena de Hematología, Santiago de Chile, Chile
14Hospital Dr Gustavo Fricke, Viña del Mar, Chile
15Clínica Los Nogales, Bogota, Colombia
16Hospital Carlos Van Buren, Valparaíso, Chile
17Hematology Department, Hospital del Norte Pemex, CDMX, Mexico
18Instituto Nacional de Cancerologia, Mexico, MEX
19Hematology, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Mexico
20Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, Mexico
21Tecnológico de Monterrey, Escuela de Medicina. TecSalud, Monterrey, NL, Mexico
22Research Division, Instituto Nacional de Cancerología, Mexico, Mexico
23Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico
24Hospital General de México, SSA, mexico, EM, Mexico
25Hematology, Hospital General del Estado, Hermosillo, SO, Mexico
26Hematologia, Universidad de Guadalajara, Hospital General de Occidente, Zapopan, Mexico
27Hematology/Oncology, University of North Carolina Hospital and Clinics, Miami, FL
28George Washington University Cancer Center, Washington, DC
29Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
30Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA

Louise Roulin, MD1*, Jean-Philippe Jais, MD-PHD2*, Alina Nicolae, MD-PHD3*, Elsa Poullot, MD4*, Cyrielle Robe5*, Francois Lemonnier, MD, PhD1*, Fabien Le Bras1*, Alizee Maarek, MD1*, Karim Belhadj, MD1*, Jehan Dupuis, MD6*, Elodie Scherman, MD6*, Mohammad Hammoud, MD6*, Taoufik El Gnaoui, MD6*, Sebastien Mule, MD, PhD7*, Emmanuel Itti, MD, PhD8*, Asma Beldi-Ferchiou, MD9*, Marie Helene Delfau Larue, MD-PHD10*, Philippe Gaulard, MD-PHD11*, Corinne Haioun, MD PhD6 and Christiane Copie, MD PhD4*

1Lymphoid Malignancies, Henri Mondor Hospital, Créteil, France
2HôPital Necker-Enfants Malades, PARIS, FRA
3Pathology, CHU Hautepierre, Strasbourg, FRA
4Pathology, Henri Mondor Hospital, Creteil, France
5Pathology, Henri Mondor Hospital, Créteil, FRA
6Lymphoid Malignancies, Henri Mondor Hospital, Creteil, France
7Radiology and Medical Imaging Department, Henri Mondor University Hospital, APHP, Créteil, France
8Service de médecine nucléaire, CHU Henri Mondor, Creteil, FRA
9Immunology, Henri Mondor Hospital, Creteil, France
10Immunology, Henri Mondor Hospital, Creteil, FRA
11Pathology, Henri Mondor Hospital, Creteil, FRA

Kathleen Maignan, NP, MSN1,2*, Shaked Peleg Azzam, MA1*, Blythe Adamson, PhD, MPH1*, Christina M. Parrinello, PhD, MPH1* and Kenneth R. Carson, MD, PhD1,3

1Flatiron Health Inc, New York, NY
2Weill Cornell Medicine, New York, NY
3Washington University School of Medicine in St. Louis, Saint Louis, MO

Evangelos Terpos, MD, PhD1, Despina Fotiou, MD1*, Konstantinos Anargyrou, MD2*, Theodoros P. Vassilakopoulos, MD, PhD3*, Dimitrios Christoulas, MD2*, Polyzois Makras, MD, PhD4*, Maria Dimou, MD, PhD5, Ioannis Ntanasis-Stathopoulos, MD1*, Stavroula Masouridou, MD3*, Maria K. Angelopoulou, MD3*, Athanasios Papatheodorou, PhD4*, Konstantinos Tsionos, MD2*, Panayiotis Panayiotidis, MD6 and Meletios A. Dimopoulos, MD7

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Department of Hematology, 251 General Air Force Hospital, Athens, Greece
3Department of Hematology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
4Department of Medical Research, 251 General Air Force Hospital, Athens, Greece
5Hematology Dept., 1st Propedeutic Internal Medicine Clinic, Laikon General Hospital, Athens, Greece
6First Department of Propedeutic Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece
7National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Prakirthi Yerram, PharmD1*, Samantha Nicole Reiss, PharmD1*, Lisa Modelevsky, PharmD1*, Lauren Schaff, MD2*, Anne Reiner, MPH3*, Katherine Panageas, DrPH3* and Christian Grommes, MD2

1Memorial Sloan Kettering Cancer Center, New York, NY
2Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan-Kettering Cancer Center, New York, NY

Neelam Mistry, MD1, Diana Abbott, PhD2*, Japera Walker Wilkison, MA3*, Ajay Major, MD, MBA4*, Brad M. Haverkos, MD, MPH, MS5 and Manali Kamdar, MD6

1Department of Internal Medicine, University of Colorado, Denver, CO
2Department of Biostatistics and Bioinformatics, University of Colorado Denver, Aurora, CO
3Department of Medicine, University of Colorado, Aurora, CO
4Department of Medicine, Internal Medicine Residency Training Program, University of Colorado, Denver, CO
5Division of Hematology, University of Colorado, Denver, CO
6Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO

Brenda M. Birmann, BA, DSc, MSc1, Kimberly Bertrand, ScD2*, Bernard Rosner, PhD3,4* and Andres Ardisson Korat3*

1Brigham and Women's Hospital and Harvard Medical School, Boston, MA
2Slone Epidemiology Center, Boston University, Boston, MA
3Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
4Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA

Daisuke Kaji, MD1,2*, Manabu Kusakabe, MD, PhD3,4*, Mamiko Sakata-Yanagimoto, MD, PhD4,5*, Yasuhito Suehara, MD1,4*, Keiichiro Hattori, MD, PhD4,5*, Yasunori Ota, MD, PhD6*, Mitsuhiro Yuasa, MD7*, Kosei Kageyama, MD2*, Yuki Taya, MD, PhD2*, Shinsuke Takagi2*, Hisashi Yamamoto, MD, PhD2*, Yuki Asano-Mori, MD, PhD2, Naoyuki Uchida, MD, PhD2, Atsushi Wake, MD, PhD2*, Shuichi Taniguchi, MD, PhD2, Go Yamamoto, MD, PhD2* and Shigeru Chiba, MD, PhD4,5

1Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
2Department of Hematology, Toranomon Hospital, Tokyo, Japan
3Department of Hematology, University of Tsukuba, Tsukuba, Japan
4Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
5Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
6Institute of Medical Science, Department of Pathology and Laboratory Medicine, The University of Tokyo, Tokyo, Japan
7Department of Hematology, Toranomon Hospital, Minato-Ku, Japan

Mattia Novo1,2*, Grzegorz Nowakowski, MD2, Ivana Micallef, MD2, Rebecca L. King, MD3, Robert Spinner, MD4*, Kay M. Ristow, BS2*, Thomas M. Habermann, MD2 and Patrick Johnston, MD, PhD2

1Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, TORINO, Italy
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Department of Nerologic Surgery, Mayo Clinic, Rochester, MN

Christin Destefano, MD1, Krista Shaw2, Ian Stewart3*, Eduard Poltavskiy3*, Kevin Chung2*, Lauren Walker3*, Nathan Boggs4*, Ying Suo5* and Adi Gundlapalli6*

1Hematology and Oncology, David Grant Medical Center, Fairfield, CA
2Uniformed Services University of the Health Sciences, Bethesda, MD
3David Grant Medical Center, Fairfield, CA
4National Institutes of Health, Bethesda, MD
5VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, UT
6VA Salt Lake City Health Care System, Salt Lake City

Lakshman Vasanthamohan, MD, FRCPC1, Brent Parker, MD2*, Joy Mangel, MD, FRCPC1, Selay Lam, MD, BSc, FRCPC1, Kang Howson-Jan, MD, FRCPC1 and Chai Wye Phua, MD, FRCPC1

1Department of Medicine, Division of Hematology, Western University, London Health Sciences Centre, London, ON, Canada
2Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada

Jesus D Gonzalez-Lugo, MD1, Ana Acuna-Villaorduna, MD1, Urvi A Shah, MD2 and Ellen W. Friedman, MD1

1Department of Hematology and Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
2Myeloma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Thais Fischer, MD1,2*, Natalia Pin Chuen Zing, MD1*, Sérgio Costa Fortier, MD1*, Talita Silveira1,2* and Carlos Sérgio Chiattone, MD1

1Hematology Division, Santa Casa de São Paulo Medical School, Sao Paulo, Brazil
2Hematology Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil

Shunfeng Hu*, Na Chen, MD*, Kang Lu, MD, PhD*, Changqing Zhen, MD, PhD*, Yi Zhao, MM* and Xin Wang, MD, PhD

Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China

Mark Bishton1*, Pier Luigi Zinzani, MD, PhD2, Scott Marshall3*, Veronica Conteh4*, Alicia Rodríguez Fernández5*, SooKyoung Kim6* and Young Nam Lee6*

1Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2University of Bologna, Istituto Di Ematologia, Bologna, Italy
3Sunderland Royal Hospital, Sunderland, United Kingdom
4Barnet Hospital, Barnet, United Kingdom
5Hospital Universitario Virgen Macarena, Seville, Spain
6Celltrion Healthcare, Incheon, Korea, Republic of (South)

Raoul Santiago, MD, MSc1,2, Johanna Ortiz Jimenez, MD1*, Reza Forghani, MD, PhD2,3,4,5*, Nikesh Muthukrishnan, MEng2*, Olivier Del Corpo, BSC, MSc6*, Shairabi Karthigesu6*, Muhammad Yahya Haider6*, Caroline Reinhold, MD, MSc3,5,6* and Sarit Assouline, MD1,2

1McGill University Jewish General Hospital, Montreal, QC, Canada
2Segal Cancer Centre and Lady Davis Institute for Medical Research, Montreal, QC, Canada
3Department of Radiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
4Gerald Bronfman Department of Oncology, Montreal, QC, Canada
5Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada
6McGill University, Montreal, QC, Canada

Joanna C Yang, MD, MPH1*, Karen Chau, BA2*, Michael Scordo, MD3, Craig S. Sauter, MD2 and Joachim Yahalom, MD 2

1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
2Memorial Sloan Kettering Cancer Center, New York, NY
3Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH